7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6h)-one and quinazolines

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6h)-one has been researched along with quinazolines in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chand, D; Kaul, A; Khajuria, A; Sharma, ML	1
Aga, MA; Ali, S; Behl, A; Hamid, A; Hussain, A; Khan, S; Mondhe, DM; Qazi, AK; Saxena, AK; Shah, BA; Singh, SK; Taneja, SC	1

Other Studies

2 other study(ies) available for 7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6h)-one and quinazolines

Article	Year
Immunopharmacological properties of azepino [2, 1-b] quinazolin-12(6H)-one-7, 8, 9, 10-tetrahydro (RLX). International journal of immunopharmacology, 1992, Volume: 14, Issue:6 Topics: Animals; Antibody Formation; Arthritis, Experimental; Bronchodilator Agents; Hypersensitivity, Delayed; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Male; Mice; Neutrophils; Pleurisy; Quinazolines; Rabbits; Rats	1992
Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer. Cancer letters, 2015, Apr-01, Volume: 359, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ehrlich Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Design; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Male; Membrane Potential, Mitochondrial; Mice; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Burden	2015

Article

Year

Immunopharmacological properties of azepino [2, 1-b] quinazolin-12(6H)-one-7, 8, 9, 10-tetrahydro (RLX).

International journal of immunopharmacology, 1992, Volume: 14, Issue:6

Topics: Animals; Antibody Formation; Arthritis, Experimental; Bronchodilator Agents; Hypersensitivity, Delayed; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Male; Mice; Neutrophils; Pleurisy; Quinazolines; Rabbits; Rats

1992

Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.

Cancer letters, 2015, Apr-01, Volume: 359, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ehrlich Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Design; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; Male; Membrane Potential, Mitochondrial; Mice; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Burden

2015